Minireviews
Copyright ©The Author(s) 2017.
World J Hepatol. Sep 8, 2017; 9(25): 1043-1053
Published online Sep 8, 2017. doi: 10.4254/wjh.v9.i25.1043
Table 3 Risk of hepatitis B virus reactivation according to different immunosuppressive drug classes (adapted from[21])
RiskDrug class
High (> 10%)B-cell depleting agents
Anthracycline
Corticosteroids high dose
Moderate (1%-10%)TNFα inhibitors
Cytokine and integrin inhibitors
Tyrosine kinase inhibitors
Corticosteroids moderate dose
Low (< 1%)Corticosteroids low dose
Traditional immunosuppression (e.g., azathioprine or methotrexate)